Found 1133 matching trials
Study Evaluating AGG-523 in Subjects With Severe Osteoarthritis Requiring Total Knee Replacement PHASE1 The main purpose of the study is to find out if, after 4 weeks of dosing, s...
Show More Location
Multiple Locations
Learn More & Join Trial
A Phase 2 Study to Evaluate Pharmacodynamics of YKP10811 in Patients With Chronic or Functional Constipation PHASE2 This will be a single-center, randomized, parallel group, multiple dose adm...
Show More Learn More & Join Trial
A Study of RO4917838 (Bitopertin) in Patients With Persistent, Predominant Negative Symptoms of Schizophrenia (WN25309) PHASE3 This multi-center, randomized, double blind, parallel-group, placebo-contro...
Show More Location
Multiple Locations
Learn More & Join Trial
Neurogenetic Pharmaceuticals (NGP) 555 in Healthy Volunteers (14 Day Multiple Ascending Dose) PHASE1 This study involves the use of an investigational drug called NGP 555. In e...
Show More Learn More & Join Trial
Efficacy and Safety Study of JTT-654 in Type 2 Diabetic Patients PHASE2 The purpose of this study is to evaluate the effect of JTT-654 on diabetes ...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of the Safety and Efficacy of Hylan G-F 20 (Synvisc) in Patients With Symptomatic Osteoarthritis of the Knee PHASE3 This clinical study is to evaluate the safety and efficacy of hylan G-F 20 ...
Show More Learn More & Join Trial
New Combination Inhaler (FlutiForm HFA MDI 100/10 µg and 250/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo in Patients With Moderate to Severe Asthma PHASE3 The purpose of this study is to compare the efficacy and safety of the fixe...
Show More Learn More & Join Trial
Evaluation of Recombinant Factor VIIa in Patients With Severe Bleeding PHASE3 This trial is conducted globally. The purpose of the trial is to evaluate t...
Show More Location
Novo Nordisk Clinical Trial Call Center
Learn More & Join Trial
A Study to Evaluate the Efficacy and Safety of Two Dose Strengths of Dalfampridine Extended Release Tablets. PHASE3 The objective of this study is to determine the effect of two dose strength...
Show More Learn More & Join Trial
Flexible Dose Titration Add-on Study to Treat Major Depressive Disorder PHASE2 Depressed patients will receive 6 weeks of citaloprma (20-40mg) therapy. Su...
Show More Location
Multiple Locations
Learn More & Join Trial